How close are we to a vaccine? What do efficacy trials actually entail? What are the challenges to achieving diversity in clinical trials? How long would a COVID-19 vaccine provide some level of protection? How is vaccine safety assessed? Should pregnant women be included in vaccine trials for COVID-19? Dr. Ruth Karron, one of the top vaccine experts in the world and a professor in International Health at the Johns Hopkins Bloomberg School of Public Health speaks to Dr. Josh Sharfstein to answer these and more questions about the COVID-19 vaccine.
